Trial Profile
Pilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV Immunization
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacogenomic; Therapeutic Use
- 16 Dec 2016 Trial focus has been changed from PD to TU.
- 13 Dec 2016 New trial record